Fasting Clinical Trial
Official title:
The Effect of Different Time-restricted Eating Windows on Body Composition
This study will examine the effect of eating timing on body composition. Previous studies
have shown that restricting food intake to 8 hours a day can result in losses in body fat and
an up-regulation of fat use. The purpose of this study is to assess changes in body
composition when the eating window time is from 6am-2pm vs 2pm-10pm.
Hypothesis: The 2-10pm eating window will result in significantly greater changes in body
composition (i.e. decreased fat mass) and the 2pm-10pm window will result in better
adherence.
Methods: Body composition (fat and lean mass) will be assessed by air displacement
densitometry (Bod Pod). Measures will be made over 4 weeks (pre-) and (post) dietary
treatment. Adherence will also be assessed by a questionnaire to determine the
ease/difficulty of the treatment.
Purpose The purpose of the study is to determine whether the eating window of a
time-restricted eating protocol affects changes in body composition. It is hypothesized that
the afternoon group will have better adherence to their experimental protocol and have
greater changes in body composition.
Sample The sample will include 20 healthy adult participants ranging in age from 18-25 that
volunteer to participate in the study. Participants will be required to have a body mass
index above 26 (BMI=weight(kg)/height(m)2). All individuals must give written informed
consent in order to participate in the study. Exclusion criteria include a history of
intermittent fasting in the past 6 months, diabetes, or pregnancy and BMI less than 25.9.
Procedure Inclusion/exclusion criteria will be explicitly stated throughout the recruitment
process. Potential participants will be recruited through advertising using posters placed
through the University of Westerns campus as well as via presentations in classrooms (using
the information from the advertising flyers). Individuals who email Bryce Knapp will be
invited to a meeting to discuss the study. After the evaluation and information meeting, the
individual will be given up to 3 days to determine if they want to participate and give their
informed consent. See attached form in the consent section of the ethics application.
Measurement: All individuals will have their body composition measured. Body composition will
be measured using air displacement densitometry "Bod Pod". Measurements will be taken twice
prior to the intervention and twice on successive days post-intervention. Individuals will
also be asked to fill out a biweekly modified dialysis diet and fluid non-adherence
questionnaires (DDFQ) with added checkboxes to record which days they complied with the
required protocol and 2 questions regarding any struggles the participants experienced. This
will be used to assess the adherence to the protocols.
Protocol: 20 participants matched for BMI will be assigned to one of two groups. The two
groups will be assigned an eating period of 6am-2pm or 2pm-10pm and instructed not to ingest
calories outside of their respective eating window. The interventions will last 4 weeks with
individuals being asked to comply to their eating window a minimum of 5 days per week. This
will be measured using the modified DDFQ. All testing will be completed by Bryce Knapp under
the supervision of Dr. Lemon. The changes in fat mass will be analyzed using a 2-way ANOVA
and the adherence will be measured using an independent t-test.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03754920 -
Prolonged Fasting With Meditation and Mild Physical Exercise
|
N/A | |
Completed |
NCT05272332 -
Gastric Ultrasound Prior to Extubation
|
||
Completed |
NCT04247464 -
Short-term Fasting as an Enhancer of Chemotherapy: Pilot Clinical Study on Colorectal Carcinoma Patients
|
N/A | |
Completed |
NCT01067001 -
Minocycline HCl Extended Release Tablets 135 mg Oral Bioequivalence Study
|
N/A | |
Completed |
NCT00757094 -
Safety and Feasibility of Fasting While Receiving Chemotherapy
|
N/A | |
Completed |
NCT01506713 -
Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT04514380 -
Effect of Drinking Carbohydrate-containing Fluids on Gastric Residual Volume in Elderly Patients
|
||
Completed |
NCT05756868 -
The Effect of Time-Restricted Feeding on Anthropometry, Biochemical Parameters, Diet Quality and Eating Behavior
|
N/A | |
Completed |
NCT05134207 -
The Effect of Oral Carbohydrate Solution on Anxiety and Comfort in Patients Undergoing Hip Arthroplasty
|
N/A | |
Completed |
NCT05031598 -
Long-term Fasting: Multi-system Adaptations in Humans
|
N/A | |
Recruiting |
NCT04501393 -
Recommended Clear Fluid Intake Volume at 2 Hours Prior to Esophagogastroduodenoscopy for Adult Patients
|
N/A | |
Enrolling by invitation |
NCT04027478 -
Can Fasting Decrease the Side Effects of Chemotherapy?
|
N/A | |
Completed |
NCT05219136 -
Improve the Comfort, Safety and Quality of Upper Endoscopy by a Modified Fasting Protocol
|
N/A | |
Recruiting |
NCT04625608 -
Effect of Premedicant Oral Paracetamol on Gastric Volume and pH
|
Phase 4 | |
Not yet recruiting |
NCT02562638 -
Pre-Procedural Fasting in Cardiac Intervention
|
N/A | |
Completed |
NCT01954836 -
Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial
|
N/A | |
Completed |
NCT01949987 -
Does Oral Intake Decreases Postoperative Pain Score in Children
|
N/A | |
Completed |
NCT01721187 -
Satiety Effects on the Neural Valuation of Food
|
N/A | |
Completed |
NCT01746719 -
Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fasting Condition
|
Phase 1 | |
Completed |
NCT01831700 -
Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions
|
Phase 1 |